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 Bradycardia is one of the adverse events associated with 
the sedatives, dexmedetomidine (DM) and propofol (PF). 
Because PF and DM attenuate the heart rate (HR) response 
to intravenous (IV) atropine, isoproterenol may be required 
for the treatment of bradycardia during DM or PF seda-
tion. Therefore, we conducted the current study to evaluate 
the effect of DM or PF on the response of HR to IV 
isoproterenol. 
 Male Sprague-Dawley rats were randomly allocated to 
one of three groups. Group C (n=7) received sodium pento-
barbital intraperitonealy and IV saline. Group PF (n=7) re-
ceived IV PF. Group DM (n=7) received IV DM. Then all 
groups received IV isoproterenol at incremental infusion 
rates (0.1, 0.3, 0.5, 1.0, and 3.0 ng/kg/min for 2 min each 
dose). 
 Blood pressure decreased significantly in the groups C 
and DM, and HR decreased significantly in group DM after 
administration of each sedative. The increases in HR at 0.5, 
1.0, and 3.0 ng/kg/min isoproterenol in group DM were 7 
5±41, 86±36, and 110±39 beats/min, respectively, and 
were greater as compared with those in group C (35±29, 
38±30, and 57±32 beats/min, respectively), but there were 
no significant differences between groups C and PF. 
 In conclusion, DM but not PF enhances the HR response 
to the continuous IV infusion of isoproterenol, suggesting 
that isoproterenol may be useful when atropine is ineffec-
tive for the treatment of bradycardia during DM or PF se-
dation. (245 words) 
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Introduction
 Alpha 2-adrenergic agonist is of interest to anesthe-
siologists because they produce sedation, anxiolysis, 
analgesia, reduction of anesthetic requirement, and 
hemodynamic stabilization." Perioperative use of 
alpha 2-adrenergic agonist may result in a decreased 
risk of adverse cardiac events, including myocardial 
ischemia.2' Dexmedetomidine (DM), a highly specific 
and selective alpha 2-adrenergic agonist, is novel sedative 
agent for intensive care." It can provide hemodynamic 
stability and appears to have no clinically important 
adverse effects on respiration." 
 The efficacy of propofol (PF) in the sedation of 
adults in the intensive care unit (ICU) is well estab-
lished, and clinical trials have demonstrated a similar 
quality of sedation to midazolam, and also a more rapid 
and predictable emergence time than midazolam.5' PF 
has been reported to have no direct negative inotropic 
effect at therapeutic concentrations in normal myocar-
dium." In clinical study, PF causes no significant 
changes in cardiac output in patients with good car-
diac function undergoing coronary artery bypass graft 
surgery." Thus PF is used with increasing frequency 
for anesthetic management or sedation in the ICU. 
 Bradycardia is one of the adverse events associated 
with both DM and PF. Furthermore, it has been re-
ported that PF and clonidine, another alpha 2-
adrenergic agonist, attenuate not only the heart rate 
(HR) response to intravenous (IV) atropine but also 
the reflex tachycardia and sympathetic response to 
hypotension. 8 -11' Thus isoproterenol may be required 
when atropine is ineffective for the treatment of 
bradycardia during DM or PF sedation. Therefore, we 
conducted the current study to evaluate the effects of 
DM and PF in comparison with pentobarbital on the 
response of HR to IV isoproterenol.
Materials and Methods
All experimental procedures and protocols described
in this study were approved by the Animal Care and 
Use Committee of Nagasaki University School of 
Medicine. After male Sprague-Dawley rats weighing 
350-400 g were anesthetized with sodium pentobarbi-
tal, intraperitoneal injection (IP) of 100 mg/kg, the 
rats were subjected to tracheotomy and ventilated with 
room air using a mechanical ventilator. Heparinised 
polyethylene catheters were inserted into the right ca-
rotid artery for recording arterial blood pressure (BP) 
and into the right external jugular vein for drug ad-
ministration. Subcutaneous electrocardiograph elec-
trodes were placed. Blood pressure (BP) and HR were 
monitored throughout the study (Nihon-Kohden RM-
6000, Tokyo, Japan). Body temperature was main-
tained at 37±1'C with a heated pad controlled by a 
rectal thermistor. 
 The experimental protocol is shown in figure 1. 
After surgical preparation and a stabilization period, 
baseline hemodynamic data were collected. The rats 
were randomly allocated to one of three groups. 
Group C (n=7) received sodium pentobarbital, IP of 50 
mg/kg followed by saline infusion. Group PF (n=7) re-
ceived IV PF at a rate of 8 mg/kg/hr throughout the 
experimental period. Group DM (n=7) received IV DM 
at a rate of 3 ,ug/kg/min for 10 min followed by sa-
line infusion. Thirty minutes after starting administra-
tion of each sedative, the next measurement was done. 
Then all groups received continuous IV infusion of 
isoproterenol at incremental infusion rates (0.1, 0.3, 
0.5, 1.0, and 3.0 ng/kg/min for 2 min each dose). BP 
and HR were measured at the end of each infusion pe-
riod. 
 All values were expressed as mean ± SD. Data 
within and among groups were analyzed with analysis 
of variance for repeated measures followed by Fisher's 
PLSD test. A p value less then 0.05 was considered 
statistically significant.
                          Pentobarbital 
                       50 mg/kg IP 
1 Group C Saline 
Group PF Propofol 8 mg/kg/hr IV 
                        Dexmedetomidine 3 jig/kg/min IV 
Group DM Saline 
                                                        Isoproterenol for 2 min at each dose 
              Surgical procedure 0 10 20 30 (min) 
     Pentobarbital 
    100 mg/kg IP
Figure 1. Experimental protocol. 
          IV=intravenous; IP=intraperitoneal injection.
Results
 Table 1 shows the data of HR and systolic, mean, 
and diastolic BP (SBP, MBP, and DBP) in this study. 
There were no significant differences among groups in 
basal HR and BP (Table 1). SBP, MBP, and DBP de-
creased significantly in the groups C and DM, and HR 
decreased significantly in group DM after administra-
tion of each sedative. Isoproterenol increased HR in a 
dose-dependent manner in all groups. BP in groups PF 
and DM significantly decreased after isoproterenol in-
fusion, but remained unchanged in group C. 
 The increases in HR after isoproterenol infusion at 
0.5, 1.0 and 3.0 ng/kg/min in group DM (75±41, 86 
± 36 and 110 ± 39 beats/min, respectively) were 
greater than those in group C (35±29, 38±30 and 57 
±32 beats/min, respectively), but there was no signifi-
cant difference between groups C and PF (Figure 2).
Table 1. Heart rate and blood pressure at each dose of in-
travenous isoproterenol 
                                                  Isoproterenol infusion rate (ng/kg/min) 
                             Pre-
            Group Baseline isoproterenol 0.1 0.3 0.5 1.0 3.0 
 HR C 428(18) 418(17) 426(25) 443(35)- 453 (42) * 456(42)- 475 (40) * 
 (bpm) PF 437(14) 440 (15) # 460 (10) * # 480 (12) * # 486 (15) * 494 (22) * 504 (14) * 
          DM 438(14)' 315 (18) # 334 (27) # 364 (41) * # 390 (46) * # 401 (40) * # 425 (37) * # 
 SBP C 151 (19) * 134(11) 131 (10) 127(14) 125(19) 123(20) 124(22) 
 (mmHg) PF 148(21) 153 (17) 152 (17) # 154 (16) # 149 (15) # 150 (16) # 144 (9) * # 
         DM 147 (11) * 128(16) 126(18) 120(17) 116(16) 111 (18) 111 (15)*
 MBP C 135 (15) * 119(11) 118(8) 113(13) 110(19) 110(21) 107(19) 
 (mmHg) PF 128 (16) 133 (13) 130 (12) 131 (12) # 131 (13) # 129 (12) # 122(9)-
         DM 130 (8) * 114(13) 111 (13) 106(11) 104(12) 97 (9) * 100(11) * 
 DBP C 120 (13) * 104(10) 102(9) 98(13) 95(18) 95(19) 91 (16) 
 (mmHg) PF 111 (13) 116(14) 112(12) 113 (13) # 112 (14) # 109(14)- 103(11)-
         DM 115 (7) * 101 (12) 98(12) 92 (8) * 92 (9) * 86 (8) * 90 (12) 
 Values are mean (SD). 
 HR = heart rate; SBP = systolic blood pressure; MBP = mean blood pressure; DBP = diastolic blood pressure. 
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Figure 2. Heart rate response to intravenous isoproterenol 
infusion at a rate of 0.1, 0.3, 0.5, 1.0, and 3.0 ng/kg/min. 
All values were expressed as mean±SD. 
*Significantly (P<0 .05) different from control.
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Discussion
 The present study showed that DM enhanced the HR 
response to continuous IV infusion of isoproterenol. It 
was reported that clonidine augmented the alpha 1-
aderenergic stimulated vasoconstriction and beta 1-
adrenergic stimulated HR increase,"' and that the HR 
response to atropine was attenuated in adults and 
children receiving clonidine in a dose-dependent man-
ner. 10, 12) The difference of the HR responses to atro-
pine and isoproterenol in the presence of clonidine 
might be due to the differential pharmacological inter-
actions of these drugs with the alpha 2-adrenergic 
agonist. Atropine increases HR by suppression of 
postganglionic parasympathetic nervous activity. The 
HR response to atropine could be attenuated by age,"' 
sympathetic nerve activity,"' co-existing disease,"" 
basal HR,"' and background anesthesia."' DM and 
clonidine reduce the central sympathetic outflow and 
the release of noradrenaline from peripheral presynaptic 
terminals,", "9' resulting in a decrease in HR. Thus at-
tenuation of the HR response to atropine in the pres-
ence of DM or clonidine may be due to reduced sym-
pathetic nervous activity and lowered basal HR 
resulting from the alpha 2-adrenergic action. 
 In contrast to atropine, isoproterenol stimulates 
postsynaptic beta 1-adrenergic receptor. It has been 
demonstrated that DM and clonidine suppress the 
stress-induced increase in the blood catecholamine 
concentration,", 10' and that these alpha 2-adrenergic 
agonists produce the up-regulation of the beta-
adrenergic receptor of the heart at a clear short time."' 
Thus it is possible that DM might enhance the HR re-
sponse to isoproterenol through the up-regulation of 
the beta-adrenergic receptor. 
 PF does not change the HR response to isoproterenol 
as compared with group C in the present study. 
Horiguchi et al. reported that PF with nitrous oxide 
anesthesia enhanced the HR response to isoproterenol 
as compared with awake patients, and suggested that 
increased sympathetic tone during isoproterenol infu-
sion might be accompanied by an increase in vagal 
tone in awake patients but not in propofol anesthe-
tized patients." The discrepancy between our and 
their results may be due to the difference of the con-
trol. Our study used pentobarbital anesthetized rats as 
control, but theirs awake humans. The balance of 
autonomic nervous activity could alter the HR re-
sponse to not only atropine"' but also isoprotereno21'. 
 BP in group DM significantly decreased after 
isoproterenol infusion, but remained unchanged in 
group C. A decrease in BP could cause a baroreceptor-
mediated tachycardia. Thus the baroreflex might
enhance the HR response to isoproterenol in group 
DM. However, it is known that a continuous infusion 
of isoproterenol increases vagal tone. Furthermore, 
clonidine was shown to attenuate both the reflex 
tachycardia and the sympathetic response to 
hypotension."' Thus the role of baroreflex seems to be 
minimum in the enhancing effect of DM on the HR re-
sponse to isoproterenol. 
 In conclusion, DM enhances the HR response to a 
continuous IV infusion of isoproterenol, whereas PF 
has no significant effect on the response. These results 
suggest that isoproterenol would be useful when atro-
pine is ineffective for the treatment of bradycardia 
during DM or PF sedation.
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